Plus Therapeutics Stock Price History

PSTV Stock  USD 1.23  0.05  4.24%   
Below is the normalized historical share price chart for Plus Therapeutics extending back to July 11, 2001. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Plus Therapeutics stands at 1.23, as last reported on the 26th of November, with the highest price reaching 1.25 and the lowest price hitting 1.16 during the day.
IPO Date
16th of November 2000
200 Day MA
1.7014
50 Day MA
1.382
Beta
0.69
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Plus Stock, it is important to understand the factors that can impact its price. Plus Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.0119, which implies the firm had a -0.0119% return per unit of risk over the last 3 months. Plus Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Plus Therapeutics' Coefficient Of Variation of (6,528), insignificant risk adjusted performance, and Variance of 32.21 to confirm the risk estimate we provide.
  
At this time, Plus Therapeutics' Common Stock Shares Outstanding is fairly stable compared to the past year. Preferred Stock And Other Adjustments is likely to climb to about 893 K in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 10.8 M in 2024. . Price To Sales Ratio is likely to drop to 1.06 in 2024. Price Earnings Ratio is likely to drop to -0.43 in 2024. Plus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0119

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsPSTV

Estimated Market Risk

 5.76
  actual daily
51
51% of assets are less volatile

Expected Return

 -0.07
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.01
  actual daily
0
Most of other assets perform better
Based on monthly moving average Plus Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Plus Therapeutics by adding Plus Therapeutics to a well-diversified portfolio.
Price Book
3.7603
Enterprise Value Ebitda
(0.30)
Price Sales
1.3165
Shares Float
5.7 M
Wall Street Target Price
16

Plus Therapeutics Stock Price History Chart

There are several ways to analyze Plus Stock price data. The simplest method is using a basic Plus candlestick price chart, which shows Plus Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceSeptember 27, 20241.85
Lowest PriceNovember 15, 20241.17

Plus Therapeutics November 26, 2024 Stock Price Synopsis

Various analyses of Plus Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Plus Stock. It can be used to describe the percentage change in the price of Plus Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Plus Stock.
Plus Therapeutics Price Action Indicator 0.05 
Plus Therapeutics Price Daily Balance Of Power 0.56 
Plus Therapeutics Price Rate Of Daily Change 1.04 

Plus Therapeutics November 26, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Plus Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Plus Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Plus Stock and then apply it to test your longer-term investment strategies against Plus.

Plus Stock Price History Data

The price series of Plus Therapeutics for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 has a statistical range of 0.68 with a coefficient of variation of 9.16. The price distribution for the period has arithmetic mean of 1.39. The median price for the last 90 days is 1.38. The company completed stock split (1:15) on 1st of May 2023. Plus Therapeutics had dividends distributed to its stock-holders on 2019-08-06.
OpenHighLowCloseVolume
11/26/2024
 1.20  1.25  1.16  1.23 
11/25/2024 1.20  1.25  1.16  1.23  115,190 
11/22/2024 1.18  1.23  1.12  1.18  461,578 
11/21/2024 1.22  1.22  1.16  1.20  26,960 
11/20/2024 1.22  1.24  1.19  1.19  15,757 
11/19/2024 1.22  1.24  1.18  1.24  36,948 
11/18/2024 1.21  1.21  1.17  1.19  28,199 
11/15/2024 1.28  1.29  1.16  1.17  133,322 
11/14/2024 1.26  1.32  1.25  1.26  82,962 
11/13/2024 1.27  1.42  1.25  1.31  128,163 
11/12/2024 1.25  1.34  1.18  1.29  96,095 
11/11/2024 1.25  1.27  1.17  1.19  63,605 
11/08/2024 1.33  1.33  1.22  1.23  106,259 
11/07/2024 1.30  1.38  1.25  1.36  127,845 
11/06/2024 1.26  1.49  1.17  1.43  1,265,954 
11/05/2024 1.45  1.45  1.33  1.36  19,367 
11/04/2024 1.38  1.38  1.33  1.36  31,414 
11/01/2024 1.33  1.37  1.32  1.35  15,269 
10/31/2024 1.32  1.32  1.29  1.32  3,371 
10/30/2024 1.35  1.36  1.31  1.32  10,125 
10/29/2024 1.35  1.35  1.30  1.35  13,593 
10/28/2024 1.35  1.35  1.32  1.35  13,884 
10/25/2024 1.35  1.35  1.29  1.35  22,169 
10/24/2024 1.41  1.41  1.34  1.35  8,049 
10/23/2024 1.36  1.38  1.32  1.38  9,769 
10/22/2024 1.40  1.42  1.35  1.38  16,224 
10/21/2024 1.45  1.45  1.38  1.40  14,116 
10/18/2024 1.44  1.45  1.41  1.44  18,763 
10/17/2024 1.39  1.45  1.39  1.41  13,031 
10/16/2024 1.39  1.43  1.34  1.43  26,554 
10/15/2024 1.32  1.45  1.31  1.41  37,484 
10/14/2024 1.42  1.42  1.20  1.32  74,855 
10/11/2024 1.34  1.40  1.31  1.37  11,726 
10/10/2024 1.32  1.32  1.28  1.30  23,315 
10/09/2024 1.35  1.39  1.31  1.36  8,960 
10/08/2024 1.38  1.41  1.32  1.35  47,971 
10/07/2024 1.39  1.50  1.30  1.41  51,160 
10/04/2024 1.33  1.34  1.28  1.30  34,320 
10/03/2024 1.46  1.46  1.21  1.30  134,130 
10/02/2024 1.34  1.46  1.33  1.41  53,745 
10/01/2024 1.31  1.46  1.29  1.31  147,331 
09/30/2024 1.86  1.88  1.34  1.46  487,504 
09/27/2024 1.57  1.94  1.55  1.85  370,270 
09/26/2024 1.55  1.65  1.54  1.54  112,040 
09/25/2024 1.53  1.55  1.50  1.54  8,516 
09/24/2024 1.60  1.60  1.50  1.53  50,380 
09/23/2024 1.59  1.60  1.53  1.59  14,365 
09/20/2024 1.58  1.64  1.50  1.64  34,696 
09/19/2024 1.69  1.74  1.50  1.60  70,666 
09/18/2024 1.60  1.76  1.60  1.62  81,790 
09/17/2024 1.58  1.59  1.51  1.59  26,088 
09/16/2024 1.50  1.56  1.46  1.51  18,490 
09/13/2024 1.49  1.50  1.46  1.48  15,870 
09/12/2024 1.35  1.48  1.28  1.43  100,033 
09/11/2024 1.35  1.38  1.30  1.35  53,505 
09/10/2024 1.23  1.28  1.18  1.26  38,660 
09/09/2024 1.37  1.41  1.15  1.22  67,384 
09/06/2024 1.42  1.46  1.35  1.41  8,959 
09/05/2024 1.41  1.42  1.37  1.38  23,196 
09/04/2024 1.58  1.58  1.37  1.44  37,629 
09/03/2024 1.44  1.57  1.44  1.51  35,685 

About Plus Therapeutics Stock history

Plus Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Plus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Plus Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Plus Therapeutics stock prices may prove useful in developing a viable investing in Plus Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding3.1 M3.3 M
Net Loss-23.3 M-24.5 M

Plus Therapeutics Stock Technical Analysis

Plus Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Plus Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Plus Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Earnings Calls Now

   

Earnings Calls

Check upcoming earnings announcements updated hourly across public exchanges
All  Next Launch Module

Plus Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Plus Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Plus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Plus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Plus Stock Analysis

When running Plus Therapeutics' price analysis, check to measure Plus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Plus Therapeutics is operating at the current time. Most of Plus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Plus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Plus Therapeutics' price. Additionally, you may evaluate how the addition of Plus Therapeutics to your portfolios can decrease your overall portfolio volatility.